Valuation Dr. Reddy's Laboratories Limited

Stocks

Market Closed - Bombay S.E. 14:02:36 23/10/2026 +04			5-day change	1st Jan Change
1,224.50 ^INR	-1.17%		-0.60%	-3.66%

10-23	Dr Reddy's rolls out new generic Ozempic brands to ease Obeda supply hit	RE
10-23	Dr. Reddy's Laboratories Limited, Q2 2027 Earnings Call, Oct 23, 2026

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	714,500	767,655	1,024,969	953,168	1,044,616	1,020,098	-	-
Change	-	7.44%	33.52%	-7.01%	9.59%	-2.35%	-	-
Enterprise Value (EV) ¹	703,980	719,330	960,383	928,633	1,011,902	993,477	967,947	941,614
Change	-	2.18%	33.51%	-3.31%	8.97%	-1.82%	-2.57%	-2.72%
P/E	30.4x	17.1x	18.4x	16.9x	24.4x	27.9x	21.1x	17.9x
PBR	3.76x	3.33x	3.63x	2.86x	2.78x	2.5x	2.27x	2.06x
PEG	-	0.2x	0.8x	13.12x	-1x	-1.9x	0.7x	1x
Capitalization / Revenue	3.33x	3.11x	3.67x	2.93x	3.11x	2.9x	2.6x	2.37x
EV / Revenue	3.28x	2.92x	3.44x	2.85x	3.01x	2.82x	2.46x	2.19x
EV / EBITDA	13.7x	11.1x	12.1x	10.8x	15.1x	16.3x	12.2x	10.4x
EV / EBIT	20.5x	13.8x	14.8x	13.4x	21.8x	23.7x	17.2x	14x
EV / FCF	52.3x	15.1x	33.1x	49.1x	30.3x	28.4x	28.3x	21.5x
FCF Yield	1.91%	6.61%	3.02%	2.04%	3.3%	3.52%	3.53%	4.66%
Dividend per Share ²	6	8	8	8	8	7.747	8.504	9.377
Rate of return	0.7%	0.87%	0.65%	0.7%	0.64%	0.63%	0.69%	0.77%
EPS ²	28.34	54.18	66.92	67.78	51.42	43.83	57.95	68.23
Distribution rate	21.2%	14.8%	12%	11.8%	15.6%	17.7%	14.7%	13.7%
Net sales ¹	214,391	246,697	279,164	325,535	335,933	351,812	392,976	430,385
EBITDA ¹	51,400	64,559	79,481	86,236	67,048	60,915	79,536	90,791
EBIT ¹	34,277	52,057	64,781	69,178	46,443	41,946	56,356	67,371
Net income ¹	23,568	45,073	55,779	56,544	42,850	36,310	48,573	56,836
Net Debt ¹	-10,520	-48,325	-64,586	-24,535	-32,714	-26,620	-52,151	-78,484
Reference price ²	861.08	924.30	1,231.03	1,144.05	1,254.65	1,224.50	1,224.50	1,224.50
Nbr of stocks (in thousands)	829,771	830,526	832,611	833,152	832,596	833,073	-	-
Announcement Date	19/05/22	10/05/23	07/05/24	09/05/25	12/05/26	-	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
DR. REDDY'S LABORATORIES LIMITED	28.38x	2.82x	16.31x	0.66%	10.75B
ELI LILLY AND COMPANY	37.06x	13.1x	27.8x	0.54%	1,135B
JOHNSON & JOHNSON	38.61x	6.49x	18.27x	2.02%	635B
ABBVIE INC.	36.46x	8.38x	17.29x	2.41%	505B
ROCHE HOLDING AG	20.87x	5.11x	12.73x	2.56%	378B
MERCK & CO., INC.	105.89x	5.92x	25.41x	2.34%	358B
NOVARTIS AG	21.76x	5.68x	13.94x	2.81%	295B
ASTRAZENECA PLC	22.43x	4.53x	12.94x	1.95%	266B
AMGEN INC.	27.87x	7.16x	12.81x	2.3%	237B
GILEAD SCIENCES, INC.	-45.48x	6.98x	27.06x	2.11%	193B
Average	29.38x	6.62x	18.45x	1.97%	401.44B
Weighted average by Cap.	35.21x	8.28x	20.38x	1.8%